236 related articles for article (PubMed ID: 18990770)
1. Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I.
Chu LW; Zhu Y; Yu K; Zheng T; Chokkalingam AP; Stanczyk FZ; Gao YT; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3268-73. PubMed ID: 18990770
[TBL] [Abstract][Full Text] [Related]
2. Variants in circadian genes and prostate cancer risk: a population-based study in China.
Chu LW; Zhu Y; Yu K; Zheng T; Yu H; Zhang Y; Sesterhenn I; Chokkalingam AP; Danforth KN; Shen MC; Stanczyk FZ; Gao YT; Hsing AW
Prostate Cancer Prostatic Dis; 2008; 11(4):342-8. PubMed ID: 17984998
[TBL] [Abstract][Full Text] [Related]
3. Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in low-risk Korean men.
Park K; Kim JH; Jeon HG; Byun SS; Lee E
Urology; 2010 Jun; 75(6):1516.e1-7. PubMed ID: 20350746
[TBL] [Abstract][Full Text] [Related]
4. Circadian variations in clock gene expression of human bone marrow CD34+ cells.
Tsinkalovsky O; Smaaland R; Rosenlund B; Sothern RB; Hirt A; Steine S; Badiee A; Abrahamsen JF; Eiken HG; Laerum OD
J Biol Rhythms; 2007 Apr; 22(2):140-50. PubMed ID: 17440215
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.
Johansson M; McKay JD; Wiklund F; Rinaldi S; Hallmans G; Bälter K; Adami HO; Grönberg H; Stattin P; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1644-50. PubMed ID: 19423539
[TBL] [Abstract][Full Text] [Related]
7. Circadian expression of clock genes in human peripheral leukocytes.
Fukuya H; Emoto N; Nonaka H; Yagita K; Okamura H; Yokoyama M
Biochem Biophys Res Commun; 2007 Mar; 354(4):924-8. PubMed ID: 17274950
[TBL] [Abstract][Full Text] [Related]
8. Correlation of sex steroids with IGF-1 and IGFBP-3 during different pubertal stages.
Kanbur-Oksüz N; Derman O; Kinik E
Turk J Pediatr; 2004; 46(4):315-21. PubMed ID: 15641264
[TBL] [Abstract][Full Text] [Related]
9. Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk.
Nam RK; Trachtenberg J; Jewett MA; Toi A; Evans A; Emami M; Narod SA; Pollak M
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1270-3. PubMed ID: 15894684
[TBL] [Abstract][Full Text] [Related]
10. The role of IGFBP3 functional polymorphisms in the risk of gastric cancer in a high-risk Chinese population.
Chen W; Wang L; Ke Q; Jin G; Tan Y; Zhou Y; Hu Z; Ma H; Wang J; Hua Z; Ding W; Shen J; Xu Y; Shen H
Eur J Cancer Prev; 2008 Apr; 17(2):82-7. PubMed ID: 18287864
[TBL] [Abstract][Full Text] [Related]
11. Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival.
Johansson M; McKay JD; Rinaldi S; Wiklund F; Adami HO; Grönberg H; Kaaks R; Stattin P
Prostate; 2009 Sep; 69(12):1281-91. PubMed ID: 19455605
[TBL] [Abstract][Full Text] [Related]
12. Postnatal ontogenesis of molecular clock in mouse striatum.
Cai Y; Liu S; Li N; Xu S; Zhang Y; Chan P
Brain Res; 2009 Apr; 1264():33-8. PubMed ID: 19171124
[TBL] [Abstract][Full Text] [Related]
13. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression.
Partonen T; Treutlein J; Alpman A; Frank J; Johansson C; Depner M; Aron L; Rietschel M; Wellek S; Soronen P; Paunio T; Koch A; Chen P; Lathrop M; Adolfsson R; Persson ML; Kasper S; Schalling M; Peltonen L; Schumann G
Ann Med; 2007; 39(3):229-38. PubMed ID: 17457720
[TBL] [Abstract][Full Text] [Related]
14. Period3 structural variation: a circadian biomarker associated with breast cancer in young women.
Zhu Y; Brown HN; Zhang Y; Stevens RG; Zheng T
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):268-70. PubMed ID: 15668506
[TBL] [Abstract][Full Text] [Related]
15. Determinants of sex hormone-binding globulin concentrations in a cross-sectional study of healthy men randomly selected.
Gomez JM; Maravall FJ; Gomez N; Navarro MA; Soler J
J Nutr Health Aging; 2007; 11(1):60-4. PubMed ID: 17315082
[TBL] [Abstract][Full Text] [Related]
16. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
[TBL] [Abstract][Full Text] [Related]
18. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
Hong SK; Han BK; Jeong JS; Jeong SJ; Moon KH; Byun SS; Lee SE
Asian J Androl; 2008 Mar; 10(2):207-13. PubMed ID: 18097534
[TBL] [Abstract][Full Text] [Related]
19. Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women - exercise and premenopausal hormones.
Tworoger SS; Missmer SA; Eliassen AH; Barbieri RL; Dowsett M; Hankinson SE
Cancer Causes Control; 2007 Sep; 18(7):743-52. PubMed ID: 17549594
[TBL] [Abstract][Full Text] [Related]
20. V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk.
Boger-Megiddo I; Weiss NS; Barnett MJ; Goodman GE; Chen C
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):286-91. PubMed ID: 18268111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]